Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

Noble Roman's (NROM) Earnings Date, Estimates & Call Transcripts

→ Shocking: One AI startup's revenue could surge 4,735% (From Manward Press) (Ad)
Free NROM Stock Alerts
$0.47
+0.02 (+3.30%)
(As of 05/17/2024 08:55 PM ET)
Compare
Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest

Earnings Summary

Latest
Earnings Date
May. 13Estimated
Actual EPS
(May. 13)
$0.02 Beat By $0.02
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

NROM Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NROM Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NROM Earnings Date and Information

Noble Roman's last announced its quarterly earnings results on May 13th, 2024. The reported $0.02 earnings per share (EPS) for the quarter. The company had revenue of $3.33 million for the quarter. Noble Roman's has generated $0.08 earnings per share over the last year ($0.08 diluted earnings per share) and currently has a price-to-earnings ratio of 5.9.

Noble Roman's Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/13/2024Q4 2023-$0.02+$0.02$0.02-$3.33 million
11/14/2023Q3 2023-$0.01+$0.01$0.01-$3.74 million
8/9/2023Q2 2023-$0.01+$0.01$0.01-$3.99 million
5/10/2023Q1 2023-$0.04+$0.04$0.04-$3.31 million
3/31/2023Q4 2022-($0.09)($0.09)($0.09)-$4.16 million
5/11/2022Q1 2022-($0.01)($0.01)($0.01)-$3.47 million
Shocking: One AI startup's revenue could surge 4,735% (Ad)

Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.

Click here to discover the AI chip company
3/22/2022Q4 2021-($0.02)($0.02)($0.02)-$3.59 million

Noble Roman's Earnings - Frequently Asked Questions

When did Noble Roman's announce their last quarterly earnings?

Noble Roman's (OTCMKTS:NROM) last announced its quarterly earning data on Monday, May 13, 2024. Learn more on NROM's earnings history.

How much revenue does Noble Roman's generate each year?

Noble Roman's (OTCMKTS:NROM) has a recorded annual revenue of $14.37 million.

How much profit does Noble Roman's generate each year?

Noble Roman's (OTCMKTS:NROM) has a recorded net income of $1.78 million. NROM has generated $0.08 earnings per share over the last four quarters.

What is Noble Roman's's price-to-earnings ratio?

Noble Roman's (OTCMKTS:NROM) has a trailing price-to-earnings ratio of 5.88.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (OTCMKTS:NROM) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Urgent Nvidia Warning
Altimetry
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
"The Biggest Drug Ever" Is Coming
Behind the Markets
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Elon’s New Device is About to Shock the World
InvestorPlace
Most important medical advance in 100 years
The Oxford Club